Opt-out testing for blood-borne viruses in primary care: a multicentre, prospective study
- PMID: 27114211
- PMCID: PMC4871304
- DOI: 10.3399/bjgp16X685225
Opt-out testing for blood-borne viruses in primary care: a multicentre, prospective study
Abstract
Background: Hepatitis B (HBV), hepatitis C (HCV), and HIV blood-borne viruses (BBV) are associated with chronic ill health and mortality. Early diagnosis reduces disease transmission, delays progression, and improves outcomes. Routine opt-out testing for BBV in primary care may be viable in identifying unknown disease.
Aim: To assess the viability and yield of routine opt-out testing for BBV.
Design and setting: A multicentre, prospective, routine opt-out testing study of BBV in primary care between September 2014 and February 2015 across four sites in Dublin, Ireland.
Method: All adult patients attending for routine blood tests were offered an additional BBV test during a 6-month period. All individuals were given an information leaflet before phlebotomy and were given the choice to opt out of BBV testing.
Results: In total, 1188 patients were invited to participate in the study and 1063 (89.5%) opted to be tested (95% confidence interval [CI] = 87.7% to 91.2%). A total of 125 patients (10.5%) opted out. There were 10 positive results, four new diagnoses, and six previously known. There were two new HBV and two new HCV diagnoses, a yield of four per 1000 (95% CI = 0.9 to 7.5 cases per 1000). No new HIV cases were diagnosed.
Conclusion: This study indicates that testing for BBV in patients presenting for routine blood tests in primary care is viable. The yield of HBV and HCV suggests that opt-out testing should be considered in primary care to increase detection rates of BBV.
Keywords: HIV; general practice; hepatitis B; hepatitis C; primary health care; screening.
© British Journal of General Practice 2016.
Figures
References
-
- Health Protection Surveillance Centre HPSC annual epidemiological report 2014. http://www.hpsc.ie/AboutHPSC/AnnualReports/File,15505,en.pdf (accessed 15 Apr 2016)
-
- Thornton L, Murphy N, Jones L, et al. Determination of the burden of hepatitis C virus infection in Ireland. Epidemiol Infect. 2012;140(8):1461–1468. - PubMed
-
- Global Burden of Hepatitis C Working Group Global burden of disease (GBD) for hepatitis C. J Clin Pharmacol. 2004;44(1):20–29. - PubMed
-
- Innes H, Hutchison S, Allen S, et al. Excess liver related morbidity of chronic hepatitis C patients who achieve a sustained viral response and are discharged from care. Hepatology. 2011;54(5):1547–1558. - PubMed
-
- Conjeeveram H. Continued progress against hepatitis C infection. JAMA. 2015;313(17):1716–1717. - PubMed
Publication types
MeSH terms
LinkOut - more resources
Full Text Sources
Other Literature Sources
Medical